Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Redeemable Convertible Preferred Shares and in Stockholders??? Equity (Capital Deficiency) (Unaudited)

v3.24.3
Condensed Consolidated Statements of Changes in Redeemable Convertible Preferred Shares and in Stockholders’ Equity (Capital Deficiency) (Unaudited) - USD ($)
$ in Thousands
Preferred Shares
Redeemable Convertible
Preferred Shares
Redeemable Convertible
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2022     $ 2 [1] $ 157,838 $ (136,801) $ 21,039
Balance (in Shares) at Dec. 31, 2022 [1]     3,122,987      
Issuance of Common Stock and warrants under February 2023 PIPE, net of issuance costs [3]     [1],[2] 1,293 1,293
Issuance of Common Stock and warrants under February 2023 PIPE, net of issuance costs (in Shares) [1],[3]     319,950      
Stock-based compensation expenses     [1] 175 175
Stock-based compensation expenses (in Shares) [1]          
Net income (loss)     (6,361) (6,361)
Balance at Mar. 31, 2023     $ 2 [1] 159,306 (143,162) 16,146
Balance (in Shares) at Mar. 31, 2023 [1]     3,442,937      
Balance at Dec. 31, 2022     $ 2 [1] 157,838 (136,801) 21,039
Balance (in Shares) at Dec. 31, 2022 [1]     3,122,987      
Net income (loss)           (20,678)
Balance at Sep. 30, 2023     $ 3 [1] 165,630 (157,479) 8,154
Balance (in Shares) at Sep. 30, 2023 [1]     4,722,733      
Balance at Mar. 31, 2023     $ 2 [1] 159,306 (143,162) 16,146
Balance (in Shares) at Mar. 31, 2023 [1]     3,442,937      
Issuance of Common Stock and warrants under February 2023 PIPE, net of issuance costs [3]     $ 1 [1] 5,858   5,859
Issuance of Common Stock and warrants under February 2023 PIPE, net of issuance costs (in Shares) [1],[3]     1,279,796      
Stock-based compensation expenses     [1] 271   271
Stock-based compensation expenses (in Shares) [1]          
Net income (loss)         (6,411) (6,411)
Balance at Jun. 30, 2023     $ 3 [1] 165,435 (149,573) 15,865
Balance (in Shares) at Jun. 30, 2023 [1]     4,722,733      
Stock-based compensation expenses     [1] 195 195
Stock-based compensation expenses (in Shares) [1]          
Net income (loss)     (7,906) (7,906)
Balance at Sep. 30, 2023     $ 3 [1] 165,630 (157,479) 8,154
Balance (in Shares) at Sep. 30, 2023 [1]     4,722,733      
Balance at Dec. 31, 2023 $ 3 [1] 166,048 (162,970) 3,081
Balance (in Shares) at Dec. 31, 2023 4,723,320 [1]      
Issuance of Common Stock, Merger Warrants and Redeemable Convertible Preferred Shares upon the APT acquisition, net of issuance cost [4] $ 12,561 $ 1 [1] 3,227 3,228
Issuance of Common Stock, Merger Warrants and Redeemable Convertible Preferred Shares upon the APT acquisition, net of issuance cost (in Shares) [4] 40,470 916,497 [1]      
Exercise of Pre-Funded Warrants into shares of Common Stock [3] [1],[2] 5 5
Exercise of Pre-Funded Warrants into shares of Common Stock (in Shares) [3]   477,827 [1]      
Issuance of Common Stock under At the Market Sales Agreement, net of $1 issuance costs [3] [1],[2] 19 19
Issuance of Common Stock under At the Market Sales Agreement, net of $1 issuance costs (in Shares) [3]   7,518 [1]      
Stock-based compensation expenses   [1] 909 909
Stock-based compensation expenses (in Shares)          
Issuance of Redeemable Convertible Preferred Shares upon March 2024 PIPE, net of issuance costs [3] $ 19,859 [1] 541   541
Issuance of Redeemable Convertible Preferred Shares upon March 2024 PIPE, net of issuance costs (in Shares) [3] 216,417 [1]      
Net income (loss)     (17,327) (17,327)
Balance at Mar. 31, 2024 $ 32,420 $ 4 [1] 170,749 (180,297) (9,544)
Balance (in Shares) at Mar. 31, 2024 256,887 6,125,162 [1]      
Balance at Dec. 31, 2023 $ 3 [1] 166,048 (162,970) 3,081
Balance (in Shares) at Dec. 31, 2023 4,723,320 [1]      
Net income (loss)           (3,214)
Balance at Sep. 30, 2024 $ 18,645 $ 6 [1] 185,429 (166,184) 37,896
Balance (in Shares) at Sep. 30, 2024 147,735 18,176,602 [1]      
Balance at Mar. 31, 2024 $ 32,420 $ 4 [1] 170,749 (180,297) (9,544)
Balance (in Shares) at Mar. 31, 2024 256,887 6,125,162 [1]      
Exercise of Pre-Funded Warrants into shares of Common Stock [3] $ 1 [1] 1
Exercise of Pre-Funded Warrants into shares of Common Stock (in Shares) [3]   980,811 [1]      
Reclassification of Redeemable convertible preferred Shares to equity $ (32,420) $ 32,420 [1] 32,420
Reclassification of Redeemable convertible preferred Shares to equity (in Shares) (256,887) 256,887 [1]      
Stock-based compensation expenses     77 77
Stock-based compensation expenses (in Shares)        
Net income (loss)       4,471 4,471
Balance at Jun. 30, 2024 $ 32,420 $ 5 [1] 170,826 (175,826) 27,425
Balance (in Shares) at Jun. 30, 2024 256,887 7,105,973 [1]      
Redeemable Convertible Preferred Shares conversion into shares of Common Stock   $ (13,775) $ 1 [1] 13,774  
Redeemable Convertible Preferred Shares conversion into shares of Common Stock (in Shares)   (109,152) 10,915,200 [1]      
Issuance of Common Stock upon restricted stock units (“RSU”) vesting   [1],[2] [2]
Issuance of Common Stock upon restricted stock units (“RSU”) vesting (in Shares)   155,429 [1]      
Stock-based compensation expenses   [1] 829 829
Stock-based compensation expenses (in Shares)   [1]      
Net income (loss)   9,642 9,642
Balance at Sep. 30, 2024 $ 18,645 $ 6 [1] $ 185,429 $ (166,184) $ 37,896
Balance (in Shares) at Sep. 30, 2024 147,735 18,176,602 [1]      
[1] All share amounts have been retroactively adjusted to reflect a 1-for-10 reverse share split as discussed in Note 10A.
[2] Less than $1.
[3] See Note 10A.
[4] See Note 1D.